A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing–remitting multiple sclerosis

✍ Scribed by Mikol, D; Lopez-Bresnahan, M; Taraskiewicz, S; Chang, P; Rangnow, J

• Book ID: 124060382
• Publisher: SAGE Publications
• Year: 2005
• Tongue: English
• Weight: 333 KB
• Volume: 11
• Category: Article
• ISSN: 1352-4585
• DOI: 10.1191/1352458505ms1197oa